Reperfusion therapy in elderly patients with acute myocardial infarction
A randomized comparison of primary angioplasty and thrombolytic therapy
Menko-Jan de Boer, MD*,*,
Jan-Paul Ottervanger, MD*,
Arnoud W. J. van’t Hof, MD*,
Jan C. A. Hoorntje, MD*,
Harry Suryapranata, MD*,
Felix Zijlstra, MD* the Zwolle Myocardial Infarction Study Group
* Department of Cardiology, Isala Clinics location "de Weezenlanden," Zwolle, Netherlands
View larger version (9K):
[in a new window]
|
Figure 1 The Kaplan-Meier curve compares the overall survival for patients randomized for angioplasty treatment (solid line) and thrombolysis treatment (dashed line) during 24 ± 6 months of follow-up (p = 0.04, relative risk: 2.5, 95% confidence interval: 1.0 to 6.2).
|
|
View larger version (10K):
[in a new window]
|
Figure 2 The Kaplan-Meier curve compares the overall survival free of recurrent infarction or stroke for patients randomized for angioplasty treatment (solid line) and thrombolysis treatment (dashed line) during 24 ± 6 months of follow-up (p = 0.003, relative risk: 3.1, 95% confidence interval: 1.4 to 7.0).
|
|
|
